As of today (2024-06-08), the Trailing Annual Dividend Yield of International Stem Cell is 0.00%.
The historical rank and industry rank for International Stem Cell's Dividend Yield % or its related term are showing as below:
ISCO's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.66 * Ranked among companies with meaningful Dividend Yield % only.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of International Stem Cell's Dividend Yield %
For the Biotechnology subindustry, International Stem Cell's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Stem Cell's Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Stem Cell's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where International Stem Cell's Dividend Yield % falls into.
International Stem Cell Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
International Stem Cell (OTCPK:ISCO) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
International Stem Cell Dividend Yield % Related Terms
Thank you for viewing the detailed overview of International Stem Cell's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
International Stem Cell (International Stem Cell) Business Description
International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. It operates in three segments, the therapeutic market, the biomedical market, and the anti-aging market. The Biomedical products business segment accounts for the majority of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ISCO has been successfully added to your 